(A) Each hospice care program shall arrange for provision of medical supplies, appliances, drugs, and biologicals to hospice patients as needed for the palliation and management of the patient's terminal illness and related conditions. The program shall ensure that drugs and biologicals are available at all times.
(B) Each hospice care program shall ensure that drugs and biologicals are administered only by the following individuals:
(1) A registered nurse, a licensed practical nurse, or a physician;
(2) A patient or a family member if approved by the attending physician; or
(3) Any other individual authorized by the Revised Code to perform this task.
(C) The individuals authorized to administer drugs or biologicals under paragraphs (B)(2) and (B)(3) of this rule and the drugs or biologicals they are authorized to administer shall be specified in the patient's plan of care.
(D) Each hospice care program licensed under this chapter that provides hospice care and services in a hospice patient's home shall establish a written policy establishing procedures to be followed in preventing the diversion of controlled substances containing opioids that are prescribed to its hospice patients. The policy shall include procedures for the disposal of any such drugs prescribed to a hospice patient as part of the patient's interdisciplinary plan of care that are relinquished to the program after the patient's death or that otherwise are no longer needed by the patient. The policy shall require that the disposal be documented by a program employee and conducted in any of the following ways:.
(1) Performed by a program employee and witnessed by the patient or patient's family member;
(2) Performed by the patient or patient's family member and witnessed by a program employee;
(3) Performed by a program employee and witnessed by another program employee.
(E) Each hospice care program shall ensure that the patient, patient's representative, and the patient's family receive a copy of the hospice care program's written policies and procedures along with education on the management and disposal of controlled drugs when a controlled substance is ordered, and document such actions in the patient's clinical record.
Five Year Review (FYR) Dates: 05/01/2019
Promulgated Under: 119.03
Statutory Authority: 3712.03
Rule Amplifies: 3712.01 , 3701.03 , 3712.06
Prior Effective Dates: 12/31/1990, 8/23/09